Loading clinical trials...
Loading clinical trials...
Phase II Study of Lenalidomide Maintenance After Salvage Therapy in Patients With Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
Conditions
Interventions
Lenalidomide 25mg
Locations
1
South Korea
Samsung Medical Center
Seoul, Gangnam-gu, South Korea
Start Date
November 16, 2018
Primary Completion Date
November 1, 2021
Completion Date
November 1, 2023
Last Updated
October 22, 2020
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions